Microbial spectrum and antibiotic susceptibility profile of Gram-positive aerobic bacteria isolated from cancer patients

Journal of Clinical Oncology

Volumn 25, Issue 36, 2007, Pages 5763-5769

  Ashour, Hossam M ^a   El Sharif, Amany ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LINEZOLID; VANCOMYCIN;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CANCER PATIENT; CANCER RESEARCH; HOSPITAL INFECTION; HUMAN; LEUKEMIA; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SKIN INFECTION; SOLID TUMOR; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; STAPHYLOCOCCUS HOMINIS; URINARY TRACT INFECTION;

ANTI-INFECTIVE AGENTS; CROSS INFECTION; EGYPT; GRAM-POSITIVE BACTERIA; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; NEOPLASMS;

EID: 37649007553     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.14.0947     Document Type: Article

References (39)

1. Andrei A, Zervos MJ: The application of molecular techniques to the study of hospital infection. Arch Pathol Lab Med 130:662-668, 2006
2. Schabrun S, Chipchase L: Healthcare equipment as a source of nosocomial infection: A systematic review. J Hosp Infect 63:239-245, 2006
3. Guinan JL, McGuckin M, Nowell PC: Management of health-care-associated infections in the oncology patient. Oncology (Williston Park) 17:415-420, 423-426, 2003
4. Bodey GP: Managing infections in the immunocompromised patient. Clin Infect Dis 40:S239, 2005 (suppl)
5. Berrouane YF, McNutt LA, Buschelman BJ, et al: Outbreak of severe Pseudomonas aeruginosa infections caused by a contaminated drain in a whirlpool bathtub. Clin Infect Dis 31:1331-1337, 2000
6. Viscoli C, Varnier O, Machetti M: Infections in patients with febrile neutropenia: Epidemiology, microbiology, and risk stratification. Clin Infect Dis 40:S240-S245, 2005 (suppl)
7. Wisplinghoff H, Seifert H, Wenzel RP, et al: Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis 36:1103-1110, 2003
8. Zinner SH: Changing epidemiology of infections in patients with neutropenia and cancer: Emphasis on Gram-positive and resistant bacteria. Clin Infect Dis 29:490-494, 1999
9. Yadegarynia D, Tarrand J, Raad I, et al: Current spectrum of bacterial infections in patients with cancer. Clin Infect Dis 37:1144-1145, 2003
10. Hughes WT, Armstrong D, Bodey GP, et al: 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 34:730-751, 2002
11. Peshkin BN, Schwartz MD, Isaacs C, et al: Utilization of breast cancer screening in a clinically based sample of women after BRCA1/2 testing. Cancer Epidemiol Biomarkers Prev 11:1115-1118, 2002
12. Cruciani M, Rampazzo R, Malena M, et al: Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: A meta-analysis. Clin Infect Dis 23:795-805, 1996
13. Mutnick AH, Kirby JT, Jones RN: CANCER resistance surveillance program: Initial results from hematology-oncology centers in North America - Chemotherapy Alliance for Neutropenics and the Control of Emerging Resistance. Ann Pharmacother 37:47-56, 2003
14. Kumashi P, Girgawy E, Tarrand JJ, et al: Streptococcus pneumoniae bacteremia in patients with cancer: Disease characteristics and outcomes in the era of escalating drug resistance (1998-2002). Medicine (Baltimore) 84:303-312, 2005
15. Ahmed R, Hassall T, Morland B, et al: Viridans streptococcus bacteremia in children on chemotherapy for cancer: An underestimated problem. Pediatr Hematol Oncol 20:439-444, 2003
16. Rolston KV, Yadegarynia D, Kontoyiannis DP, et al: The spectrum of Gram-positive bloodstream infections in patients with hematologic malignancies, and the in vitro activity of various quinolones against Gram-positive bacteria isolated from cancer patients. Int J Infect Dis 10:223-230, 2006
17. Diekema DJ, Jones RN, Rolston KV: Antimicrobial activity of gatifloxacin compared to seven other compounds tested against gram-positive organisms isolated at 10 cancer-treatment centers. Diagn Microbiol Infect Dis 34:37-43, 1999
18. Diekema DJ, Coffman SL, Marshall SA, et al: Comparison of activities of broad-spectrum beta-lactam compounds against 1,128 gram-positive cocci recently isolated in cancer treatment centers. Antimicrob Agents Chemother 43:940-943, 1999
19. Drew WL, Barry AL, O'Toole R, et al: Reliability of the Kirby-Bauer disc diffusion method for detecting methicillin-resistant strains of Staphylococcus aureus. Appl Microbiol 24:240-247, 1972
20. Cafferkey M: Methicillin-resistant Staphylococcus Aureus: Clinical Management and Laboratory Aspects (Infectious Disease and Therapy). New York, NY, Marcel Dekler Inc, 1992
21. Lyytikäinen O, Lumio J, Sarkkinen H, et al: Nosocomial bloodstream infections in Finnish hospitals during 1999-2000. Clin Infect Dis 35:e14-e19, 2002
22. Madani TA: Clinical infections and bloodstream isolates associated with fever in patients undergoing chemotherapy for acute myeloid leukemia. Infection 28:367-373, 2000
23. Friedman ND, Kaye KS, Stout JE, et al: Health care-associated bloodstream infections in adults: A reason to change the accepted definition of community-acquired infections. Ann Intern Med 137:791-797, 2002
24. Marchetti O, Calandra T: Infections in neutropenic cancer patients. Lancet 359:723-725, 2002
25. Hoheisel G, Lange S, Winkler J, et al: Nosocomial pneumonias in haematological malignancies in the medical intensive care unit [in German]. Pneumologie 57:73-77, 2003
26. Jesus Hernandez-Navarrete M, Arribas-Llorente JL, Solano-Bernad VM, et al: Quality improvement program of nosocomial infection in colorectal cancer surgery [in Spanish]. Med Clin (Barc) 125:521-524, 2005
27. Barber GR, Miransky J, Brown AE, et al: Direct observations of surgical wound infections at a comprehensive cancer center. Arch Surg 130:1042-1047, 1995
28. Vilar-Compte D, Mohar A, Sandoval S, et al: Surgical site infections at the National Cancer Institute in Mexico: A case-control study. Am J Infect Control 28:14-20, 2000
29. El Kholy A, Baseem H, Hall GS, et al: Antimicrobial resistance in Cairo, Egypt 1999-2000: A survey of five hospitals. J Antimicrob Chemother 51:625-630, 2003
30. Cepeda JA, Whitehouse T, Cooper B, et al: Isolation of patients in single rooms or cohorts to reduce spread of MRSA in intensive-care units: Prospective two-centre study. Lancet 365:295-304, 2005
31. Melo-Cristino J: Antimicrobial resistance in staphylococci and enterococci in 10 Portuguese hospitals in 1996 and 1997: POSGAR - Portuguese Study Group of Antimicrobial Resistance. Microb Drug Resist 4:319-324, 1998
32. Schmitz FJ, Lindenlauf E, Hofmann B, et al: The prevalence of low- and high-level mupirocin resistance in staphylococci from 19 European hospitals. J Antimicrob Chemother 42:489-495, 1998
33. Tiwari HK, Sen MR: Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India. BMC Infect Dis 6:156, 2006
34. Appelbaum PC: The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus. Clin Microbiol Infect 12:16-23, 2006 (suppl)
35. Stevens DL, Herr D, Lampiris H, et al: Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Clin Infect Dis 34:1481-1490, 2002
36. Wunderink RG, Rello J, Cammarata SK, et al: Linezolid vs vancomycin: Analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest 124:1789-1797, 2003
37. Rolston KV, Frisbee-Hume S, LeBlanc B, et al: In vitro antimicrobial activity of moxifloxacin compared to other quinolones against recent clinical bacterial isolates from hospitalized and community-based cancer patients. Diagn Microbiol Infect Dis 47:441-449, 2003
38. Rolston KV, Vaziri I, Frisbee-Hume S, et al: In vitro antimicrobial activity of gatifloxacin compared with other quinolones against clinical isolates from cancer patients. Chemotherapy 50:214-220, 2004
39. Diekema DJ, Beach ML, Pfaller MA, et al: Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin America. Clin Microbiol Infect 7:152-157, 2001